- Home
- TELO vs YXT Comparison
TELO vs YXT Comparison
Compare TELO & YXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TELO
- YXT
- Stock Information
- Founded
- TELO 2021
- YXT 2011
- Country
- TELO United States
- YXT China
- Employees
- TELO N/A
- YXT N/A
- Industry
- TELO
- YXT
- Sector
- TELO
- YXT
- Exchange
- TELO NYSE
- YXT NYSE
- Market Cap
- TELO 52.4M
- YXT 46.0M
- IPO Year
- TELO 2024
- YXT 2024
- Fundamental
- Price
- TELO $2.19
- YXT $0.86
- Analyst Decision
- TELO
- YXT
- Analyst Count
- TELO 0
- YXT 0
- Target Price
- TELO N/A
- YXT N/A
- AVG Volume (30 Days)
- TELO 9.2M
- YXT 26.7K
- Earning Date
- TELO 08-12-2025
- YXT 08-21-2025
- Dividend Yield
- TELO N/A
- YXT N/A
- EPS Growth
- TELO N/A
- YXT N/A
- EPS
- TELO N/A
- YXT N/A
- Revenue
- TELO N/A
- YXT $45,374,087.00
- Revenue This Year
- TELO N/A
- YXT N/A
- Revenue Next Year
- TELO N/A
- YXT N/A
- P/E Ratio
- TELO N/A
- YXT $1.39
- Revenue Growth
- TELO N/A
- YXT N/A
- 52 Week Low
- TELO $1.12
- YXT $0.47
- 52 Week High
- TELO $8.40
- YXT $11.00
- Technical
- Relative Strength Index (RSI)
- TELO 64.07
- YXT N/A
- Support Level
- TELO $2.00
- YXT N/A
- Resistance Level
- TELO $2.44
- YXT N/A
- Average True Range (ATR)
- TELO 0.19
- YXT 0.00
- MACD
- TELO 0.15
- YXT 0.00
- Stochastic Oscillator
- TELO 54.04
- YXT 0.00
About TELO TELOMIR PHARMACEUTICALS INC
Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company which leads the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.
About YXT YXT.COM GROUP HOLDING LIMITED SPON ADS EA REP 3 CL A SHS
Yxt.Com Group Holding Ltd operates as a technology company. The company has created a SaaS model that integrates software and content, assisting customers in the digital transformation of corporate learning. The company operates in the People's Republic of China.